Literature DB >> 18557866

Barriers to HIV testing for migrant black Africans in Western Europe.

I Fakoya1, R Reynolds, G Caswell, I Shiripinda.   

Abstract

Migrant black Africans are disproportionately affected by HIV in Western Europe; we discuss the barriers to HIV testing for sub-Saharan migrants, with particular emphasis on the UK and the Netherlands. Cultural, social and structural barriers to testing, such as access to testing and care, fear of death and disease and fear of stigma and discrimination in the community, can be identified. Lack of political will, restrictive immigration policies and the absence of African representation in decision-making processes are also major factors preventing black Africans from testing. HIV testing strategies need to be grounded in outreach and community mobilisation, addressing fear of diagnosis, highlighting the success of treatment and tackling HIV-related stigma among black African migrant communities.

Entities:  

Mesh:

Year:  2008        PMID: 18557866     DOI: 10.1111/j.1468-1293.2008.00587.x

Source DB:  PubMed          Journal:  HIV Med        ISSN: 1464-2662            Impact factor:   3.180


  39 in total

1.  What Prevents Central Asian Migrant Workers from Accessing HIV Testing? Implications for Increasing HIV Testing Uptake in Kazakhstan.

Authors:  Alissa Davis; Assel Terlikbayeva; Dina Terloyeva; Sholpan Primbetova; Nabila El-Bassel
Journal:  AIDS Behav       Date:  2017-08

Review 2.  Mobility and HIV in Central America and Mexico: a critical review.

Authors:  Shira M Goldenberg; Steffanie A Strathdee; Maria D Perez-Rosales; Omar Sued
Journal:  J Immigr Minor Health       Date:  2012-02

3.  All black people are not alike: differences in HIV testing patterns, knowledge, and experience of stigma between U.S.-born and non-U.S.-born blacks in Massachusetts.

Authors:  Bisola Ojikutu; Chioma Nnaji; Juliet Sithole; Karen L Schneider; Molly Higgins-Biddle; Kevin Cranston; Felton Earls
Journal:  AIDS Patient Care STDS       Date:  2012-12-21       Impact factor: 5.078

4.  Differences in recourse to HIV testing according to migration origin in the Paris metropolitan area in 2010.

Authors:  Annabelle Lapostolle; Véronique Massari; Nathalie Beltzer; Sandrine Halfen; Pierre Chauvin
Journal:  J Immigr Minor Health       Date:  2013-08

5.  Economic and public health consequences of delayed access to medical care for migrants living with HIV in France.

Authors:  Marlène Guillon; Michel Celse; Pierre-Yves Geoffard
Journal:  Eur J Health Econ       Date:  2017-03-25

6.  Molecular epidemiology of HIV-1 infection in immigrant population in northern Italy.

Authors:  Caterina Sagnelli; Caterina Uberti-Foppa; Sabrina Bagaglio; Eleonora Cella; Vittoria Scolamacchia; Hamid Hasson; Stefania Salpietro; Emanuela Messina; Giulia Morsica; Silvia Angeletti; Massimo Ciccozzi; Adriano Lazzarin; Evangelista Sagnelli
Journal:  Epidemiol Infect       Date:  2020-02-05       Impact factor: 2.451

7.  Impact of socio-demographic factors on HIV testing among African immigrants in Portugal.

Authors:  Ana Gama; Sílvia Fraga; Sónia Dias
Journal:  J Immigr Minor Health       Date:  2010-12

8.  Analysis of risk factors for late presentation in a cohort of HIV-infected patients in Dresden: positive serology for syphilis in MSM is a determinant for earlier HIV diagnosis.

Authors:  P Spornraft-Ragaller; U Boashie; V Stephan; J Schmitt
Journal:  Infection       Date:  2013-06-01       Impact factor: 3.553

9.  Assessing the role of individual and neighbourhood characteristics in HIV testing: evidence from a population based survey.

Authors:  Maninder Singh Setia; Amelie Quesnel-Vallee; Sarah Curtis; John Lynch
Journal:  Open AIDS J       Date:  2009-10-15

10.  Hepatitis B screening in the Turkish-Dutch population in Rotterdam, the Netherlands; qualitative assessment of socio-cultural determinants.

Authors:  Ytje Jj van der Veen; Onno de Zwart; Hélène Acm Voeten; Johan P Mackenbach; Jan Hendrik Richardus
Journal:  BMC Public Health       Date:  2009-09-09       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.